IN8bio Inc

XNAS:INAB 4:00:00 PM EDT

1.50

+0.06 (+4.17%)

7:40:45 PM EDT: $1.51 +0.01 (+0.67%)

IN8bio Inc Stock, XNAS:INAB

350 5th Avenue, Suite 5330, New York, New York 10118

United States of America

Phone: +1.646.600.6438

Number of Employees: 18

http://www.in8bio.com

Description

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.